Real-world safety and effectiveness of elexacaf tor/tezacaf tor/ivacaf tor in people with cystic fibrosis: Interim results of a long-term registry-based study

Bower, JK; Volkova, N; Ahluwalia, N; Sahota, G; Xuan, FJ; Chin, A; Weinstock, TG; Ostrenga, J; Elbert, A

Bower, JK (通讯作者)，Vertex Pharmaceut Inc, 50 Northern Ave, Boston, MA 02210 USA.

JOURNAL OF CYSTIC FIBROSIS, 2023; 22 (4): 730

Abstract

Background: Phase 3 clinical trials showed elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) was safe and efficacious in people with cystic fibrosis (CF)......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索